cefoperazone has been researched along with E coli Infections in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Ali, I; Shabbir, M | 1 |
| Fujimori, N; Horiuchi, K; Joshita, S; Kasuga, E; Komatsu, M; Matsumoto, A; Sugiura, A; Tanaka, E; Umemura, T; Yamazaki, T | 1 |
| Chen, JH; Feng, W; Ou, QY; Shi, HQ; Sun, FJ; Xia, PY; Yong, XL | 1 |
| Fessler, AT; Kaspar, H; Lindeman, CJ; Mankertz, J; Peters, T; Schwarz, S; Stegemann, MR; Watts, JL | 1 |
| Gao, ZH; Li, SM; Shen, JH; Zhang, BY | 1 |
| Homberger, F; Kayser, FH; Morenzoni, G | 1 |
| Catarinelli, L; Celi, F; Crapa, G; De Rosa, F; Frongillo, RF; Luzzi, L; Moretti, MV; Palumbo, M; Rossi, A; Sciannameo, F | 1 |
| Chandrasekar, PH; Kruse, JA; Sluchak, JA | 1 |
| Ciebieda, I; Denys, A; Ferszt, T; Korczak, E | 1 |
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Guiot, HF; Hazekamp-van Dokkum, AM; Mattie, H; van Furth, R; van Ogtrop, ML; van Strijen, E | 1 |
| Coppola, L; Cristiano, P; Iannece, MD; Leonessa, V; Pempinello, R; Rescigno, C | 1 |
| Bollinger, M; Greenberg, RN; Kennedy, DJ; Reilly, PM; Weinandt, WJ | 1 |
| Agger, N; Gilbert, GA; Thomasson, CA; Tolling, ST; Wilson, CD | 1 |
| Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
| Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
| Butt, KM; Goldstein, EJ; Gombert, ME; Sierra, MF | 1 |
1 review(s) available for cefoperazone and E coli Infections
| Article | Year |
|---|---|
A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
Topics: Aged; Ampicillin; Cefoperazone; Coinfection; Desulfovibrio desulfuricans; Desulfovibrionaceae Infections; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Liver Abscess; Meropenem; Thienamycins | 2018 |
1 trial(s) available for cefoperazone and E coli Infections
| Article | Year |
|---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
16 other study(ies) available for cefoperazone and E coli Infections
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Opposite effects of cefoperazone and ceftazidime on S‑ribosylhomocysteine lyase/autoinducer-2 quorum sensing and biofilm formation by an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carbon-Sulfur Lyases; Cefoperazone; Ceftazidime; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Quorum Sensing; RNA, Messenger | 2014 |
A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefoperazone; Escherichia coli; Escherichia coli Infections; Female; Germany; Mastitis, Bovine; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus; United States | 2012 |
[Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Host-Pathogen Interactions; Male; Microscopy, Electron, Transmission; Molecular Sequence Data; Peptides; Rabbits; Snake Venoms; Sulbactam; Urinary Bladder; Urinary Tract Infections | 2013 |
Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.
Topics: Ampicillin; Bacteria; beta-Lactamases; Cefoperazone; Cephalosporins; Conjugation, Genetic; Culture Media; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Time Factors | 1982 |
[Our experience with sodium cefoperazone].
Topics: Amikacin; Cefoperazone; Drug Synergism; Escherichia coli Infections; Humans; Meningitis; Pseudomonas Infections; Urinary Tract Infections | 1984 |
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
Topics: Agranulocytosis; Animals; beta-Lactamases; Cefoperazone; Colony Count, Microbial; Cyclophosphamide; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1993 |
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts | 1992 |
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.
Topics: Animals; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Female; Mice | 1990 |
Cefoperazone therapy of bacterial meningitis: a preliminary report.
Topics: Adolescent; Adult; Aged; Cefoperazone; Child; Drug Evaluation; Escherichia coli Infections; Female; Humans; Male; Meningitis; Meningitis, Meningococcal; Middle Aged | 1987 |
Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Cefoperazone; Drug Combinations; Drug Evaluation; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Sulbactam; Urinary Tract Infections | 1987 |
Field trials with cefoperazone in the treatment of bovine clinical mastitis.
Topics: Animals; Cattle; Cefoperazone; Denmark; Escherichia coli; Escherichia coli Infections; Female; France; Mastitis, Bovine; Milk; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Sweden; United Kingdom | 1986 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Cefoperazone therapy of complicated urinary tract infections: pharmacokinetics in renal transplant recipients.
Topics: Adult; Aged; Cefoperazone; Creatinine; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pseudomonas Infections; Pyelonephritis; Serratia marcescens; Urinary Tract Infections | 1985 |